May, 2010
No. 95 (5)

Editorials

Review Articles

Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia (5444 Online Views)

Sophie Park, Nicolas Chapuis, Jérôme Tamburini, Valérie Bardet, Pascale Cornillet-Lefebvre, Lise Willems, Alexa Green, Patrick Mayeux, Catherine Lacombe, Didier Bouscary

https://doi.org/10.3324/haematol.2009.013797

Articles

Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship (1885 Online Views)

Achille Iolascon, Roberta Russo, Maria Rosaria Esposito, Roberta Asci, Carmelo Piscopo, Silverio Perrotta, Madeleine Fénéant-Thibault, Loïc Garçon, Jean Delaunay

https://doi.org/10.3324/haematol.2009.014985

A mechanism of ineffective erythropoiesis in β-thalassemia/Hb E disease (1217 Online Views)

Pathrapol Lithanatudom, Amporn Leecharoenkiat, Tirawat Wannatung, Saovaros Svasti, Suthat Fucharoen, Duncan R. Smith

https://doi.org/10.3324/haematol.2009.015701

Complications and treatment of patients with β-thalassemia in France: results of the National Registry (1370 Online Views)

Isabelle Thuret, Corinne Pondarré, Anderson Loundou, Dominique Steschenko, Robert Girot, Dora Bachir, Christian Rose, Vincent Barlogis, Jean Donadieu, Mariane de Montalembert, Isabelle Hagege, Brigitte Pegourie, Claire Berger, Marguerite Micheau, Françoise Bernaudin, Thierry Leblanc, Laurence Lutz, Frédéric Galactéros, Marie-Claude Siméoni, Catherine Badens

https://doi.org/10.3324/haematol.2009.018051

Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis (1422 Online Views)

Philipp Erben, Darko Gosenca, Martin C. Müller, Jelena Reinhard, Joannah Score, Francesco del Valle, Christoph Walz, Jürgen Mix, Georgia Metzgeroth, Thomas Ernst, Claudia Haferlach, Nicholas C.P. Cross, Andreas Hochhaus, Andreas Reiter

https://doi.org/10.3324/haematol.2009.016345

Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients (821 Online Views)

María Carmen Chillón, Carlos Santamaría, Ramón García-Sanz, Ana Balanzategui, Sarasquete María Eugenia, Miguel Alcoceba, Luis Marín, María Dolores Caballero, María Belén Vidriales, Fernando Ramos, Teresa Bernal, Joaquín Díaz-Mediavilla, Alfonso García de Coca, María Jesús Peñarrubia, José Antonio Queizán, Pilar Giraldo, Jesús F. San Miguel, Marcos González

https://doi.org/10.3324/haematol.2009.015073

Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia (787 Online Views)

Mariël L. te Winkel, Robert D. van Beek, Sabine M.P.F. de Muinck Keizer-Schrama, André G. Uitterlinden, Wim C.J. Hop, Rob Pieters, Marry M. van den Heuvel-Eibrink

https://doi.org/10.3324/haematol.2009.016303

C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway (989 Online Views)

Natasa Anastasov, Irina Bonzheim, Martina Rudelius, Margit Klier, Therese Dau, Daniela Angermeier, Justus Duyster, Stefania Pittaluga, Falko Fend, Mark Raffeld, Leticia Quintanilla-Martinez

https://doi.org/10.3324/haematol.2009.014050

CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia (1150 Online Views)

Mercedes Borge, Paula Romina Nannini, Jeremías Gastón Galletti, Pablo Elías Morande, Julio Sánchez Ávalos, Raimundo Fernando Bezares, Mirta Giordano, Romina Gamberale

https://doi.org/10.3324/haematol.2009.013995

Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells (2038 Online Views)

Sally K. Martin, Peter Diamond, Sharon A. Williams, Luen Bik To, Daniel J. Peet, Nobutaka Fujii, Stan Gronthos, Adrian L. Harris, Andrew C.W. Zannettino

https://doi.org/10.3324/haematol.2009.015628

Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells (1394 Online Views)

Djordje Atanackovic, York Hildebrandt, Adam Jadczak, Yanran Cao, Tim Luetkens, Sabrina Meyer, Sebastian Kobold, Katrin Bartels, Caroline Pabst, Nesrine Lajmi, Maja Gordic, Tanja Stahl, Axel R. Zander, Carsten Bokemeyer, Nicolaus Kröger

https://doi.org/10.3324/haematol.2009.014464

In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma (2514 Online Views)

Enrique M. Ocio, David Vilanova, Peter Atadja, Patricia Maiso, Edvan Crusoe, Diego Fernández-Lázaro, Mercedes Garayoa, Laura San-Segundo, Teresa Hernández-Iglesias, Enrique de Álava, Wenlin Shao, Yung-Mae Yao, Atanasio Pandiella, Jesús F. San-Miguel

https://doi.org/10.3324/haematol.2009.015495

Primary plasma cell leukemia and autologous stem cell transplantation (2029 Online Views)

Mary B. Drake, Simona Iacobelli, Anja van Biezen, Curly Morris, Jane F. Apperley, Dietger Niederwieser, Bo Björkstrand, Gösta Gahrton

https://doi.org/10.3324/haematol.2009.013334

Brief Reports

Erythrocytosis associated with a novel missense mutation in the HIF2A gene (638 Online Views)

Richard van Wijk, Scott Sutherland, Annet C.W. Van Wesel, Eric G. Huizinga, Melanie J. Percy, Marc Bierings, Frank S. Lee

https://doi.org/10.3324/haematol.2009.017582

The therapeutic response and clinical outcome of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience (494 Online Views)

Giuseppe Cimino, Natalia Cenfra, Loredana Elia, Simona Sica, Mario Luppi, Giovanna Meloni, Marco Vignetti, Francesca Paoloni, Robin Foà, Franco Mandelli

https://doi.org/10.3324/haematol.2009.009035

Constitutional mismatch repair deficiency and childhood leukemia/lymphoma – report on a novel biallelic MSH6 mutation (1146 Online Views)

Tim Ripperger, Carmela Beger, Nils Rahner, Karl W. Sykora, Clemens L. Bockmeyer, Ulrich Lehmann, Hans H. Kreipe, Brigitte Schlegelberger

https://doi.org/10.3324/haematol.2009.015503

A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma (1911 Online Views)

Mohamad Hussein, James R. Berenson, Ruben Niesvizky, Nikhil Munshi, Jeffrey Matous, Ronald Sobecks, Kate Harrop, Jonathan G. Drachman, Nancy Whiting

https://doi.org/10.3324/haematol.2009.008003

Letters to the Editor


Thalassemia Syndromes


Acute Promyelocytic Leukemia

Errata Corrige